Tam says cancelled AstraZeneca update was not related to safety concerns

COVID Cda 20210312

Canada’s chief public health officer said today the National Advisory Committee on Immunization (NACI) recently punted a planned update to its AstraZeneca guidance because it wanted to incorporate new data about the prevalence of COVID-19 variants in this country — not because there’s been a safety development.

Leave a Reply

Your email address will not be published. Required fields are marked *